Literature DB >> 12149903

[Perthes disease].

J Kramer1, S Hofmann, A Scheurecker, C Tschauner.   

Abstract

The Legg-Calve-Perthes disease is an idiopathic avascular necrosis of the hip during early childhood. It is characterized by different stages with the main risk of persisting hip deformation, dysfunction of the joint movement, and the potential for early osteoarthritis. For the evaluation of prognosis and therapy planning patients age and extent of the necrotic area of the epiphysis are important factors. For an early diagnosis and sufficient therapy all radiological efforts have to be performed. MR imaging is an ideal method for the assessment of osteonecrotic changes of the Morbus Perthes. Compared to plain radiography by MR imaging pathologic alterations can be detected earlier and with higher specificity. However, conventional radiograms have to be still used as basic imaging modality. Nowadays x-rays and MR imaging should be the main methods for the evaluation of children suffering from Perthes disease.

Entities:  

Mesh:

Year:  2002        PMID: 12149903     DOI: 10.1007/s00117-002-0755-9

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  4 in total

Review 1.  [Perthes disease-diagnosis, classification and treatment based on Aachen-Dortmund treatment algorithm].

Authors:  K Rosery; M Tingart; C Lüring; A Schulze
Journal:  Orthopade       Date:  2018-09       Impact factor: 1.087

2.  Microcephaly associated with Legg-Calvè-Perthes disease in two siblings.

Authors:  Salvatore Savasta; Martino Ruggieri; Piero Pavone; Andrea Domenico Praticò; Agata Polizzi; Giampiero Beluffi; Vito Pavone
Journal:  Neurol Sci       Date:  2012-01-06       Impact factor: 3.307

Review 3.  [Femoral head necrosis].

Authors:  J Kramer; G Scheurecker; A Scheurecker; A Stöger; A Huber; S Hofmann
Journal:  Radiologe       Date:  2009-05       Impact factor: 0.635

4.  [Modified PemberSal osteotomy technique with lyophilized human allograft].

Authors:  C Druschel; K Heck; C Kraft; R Placzek
Journal:  Oper Orthop Traumatol       Date:  2016-09-14       Impact factor: 1.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.